-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Upgrades Chemed to Buy, Raises Price Target to $620

Benzinga·10/28/2026 22:09:30
Listen to the news
Jefferies analyst Brian Tanquilut upgrades Chemed (NYSE:CHE) from Hold to Buy and raises the price target from $520 to $620.